From: Research progress on non-protein-targeted drugs for cancer therapy
Delivery platform | Classification | Pros | Cons |
---|---|---|---|
Viral vectors | Adenovirus, adeno-associated virus, lentivirus | High transfection efficiency | Immunogenicity, high cost, toxicity |
Lipid-based delivery system | Micelles, liposomes, lipid nanoparticles | Easy to production, lack of immunogenicity, biodegradability | Difficult to large-scale |
Polymer-based nanoparticles | Cationic polymers, dendrimers | Small size, low immunogenicity and toxicity | Poor biodegradability |
Inorganic nanoparticles | Gold nanoparticles, silica nanoparticles, carbon nanotubes | Easy functionalization, good biocompatibility, high load capacity, mass production | Limited transfection efficiency, lack of clinical trials |